Opioid addiction remains one of the most enduring health crises: in 2022, some 60 million people used opioids nonmedically, and only 1 in 11 with a drug use disorder received treatment. The most critical moment often occurs during withdrawal, when symptoms explode and many abandon the treatment pathway.
Faced with this dreaded phase, Indian researchers tested an unexpected approach: combining a structured yoga module with standard buprenorphine care. Their clinical trial, published in the journal JAMA Psychiatrysuggests that this combination could significantly accelerate the stabilization of weaning… with striking figures.
Opioid withdrawal: an overheated nervous system
Opioid use disorder (OUD) profoundly disrupts
autonomic nervous system. The sympathetic system, that of the “fight or flight” reaction, remains in hyperactivity: racing heart, sweating, anxiety, insomnia… The parasympathetic, linked to rest and digestion, no longer plays its role as a brake, which fuels craving (withdrawal) and relapses during withdrawal.
To objectify this imbalance, the authors point out that “Recent evidence indicates that dysregulation of the autonomic nervous system, evidenced by reduced heart rate variability, is associated with more intense cravings and greater vulnerability to relapse in opioid use disorder“, the study authors wrote in
JAMA Psychiatry. Essential for withdrawal, traditional medications, such as buprenorphine, do not fully correct the imbalance in the autonomic nervous system characterized by a decrease in parasympathetic activity and an increase in sympathetic activity.
A clinical trial of yoga as a complement to buprenorphine
The randomized trial was conducted at NIMHANS, Bengaluru (India), among 59 men aged 18 to 50 years, hospitalized for OUD with mild to moderate withdrawal. All received standard treatment with buprenorphine. They were divided into either a “usual treatment” group (TAU), or a “complementary yoga therapy” group (YAT), which added a module of yoga dedicated to opioid withdrawal of 10 supervised sessions of 45 minutes over 14 days (relaxation, gentle postures, pranayama-type breathing, guided relaxation).
After 14 days of testing, it was clear that yoga had a significant impact on recovery in the group that practiced yoga. Participants who received yoga therapy in addition to standard care experienced a faster recovery, with a median duration of 5 days, compared to 9 days for the control group, a recovery rate 4.4 times faster. The yoga group also fell asleep an average of 61 minutes faster, with significantly reduced anxiety and perceived pain.
What yoga changes in the body during withdrawal
The authors summarize the issue as follows: “By shortening the withdrawal period, when relapse risk and dropout rates are highest, yoga can influence these trajectories and potentially improve retention and long-term outcomes.“.
On a physiological level, yoga improved HRV: increase in the high frequency component (parasympathetic activity) and decrease in the low frequency/high frequency ratio, a sign of rebalancing of the autonomic nervous system. A mediation analysis shows that approximately 23% of the effect of yoga on the speed of recovery can be explained by this increase in parasympathetic activity.
The authors believe that although most of the participants were addicted to tapentadol, the authors believe that “The sympathovagal benefits of yoga likely extend to other opioids, but replication in diverse settings and fentanyl-dependent populations is needed.”. The study therefore remains early, carried out in a single center and only among men, but it opens up a concrete avenue for the integration of yoga as a complementary therapy, without replacing drug treatments and psychosocial support.